1. Home
  2. PALI

as 04-18-2025 1:41pm EST

$
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Nasdaq

Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.

Founded: 1996 Country:
United States
United States
Employees: N/A City: CARLSBAD
Market Cap: 3.2M IPO Year: N/A
Target Price: $23.00 AVG Volume (30 days): 71.2K
Analyst Decision: Strong Buy Number of Analysts: 2
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -10.19 EPS Growth: N/A
52 Week Low/High: $0.60 - $9.09 Next Earning Date: 05-12-2025
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

PALI Daily Stock ML Predictions

Share on Social Networks: